Understand Abnormal Menstrual Bleeding (Menorrhagia) with comprehensive information for healthcare professionals. This resource covers clinical documentation, medical coding, and Irregular Menstrual Bleeding, including Heavy Menstrual Bleeding, for accurate diagnosis and patient care. Learn about Menorrhagia symptoms, causes, and treatment options relevant to healthcare providers and coding specialists.
Also known as
Excessive, frequent, and irregular menstruation
Covers various abnormal menstrual bleeding patterns.
Other abnormal bleeding from female genital tract
Includes bleeding not classified elsewhere, like postcoital.
Unspecific hematuria
May be relevant if blood in urine occurs during menstruation.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the abnormal menstrual bleeding due to an underlying medical condition?
When to use each related code
| Description |
|---|
| Heavy or prolonged menstrual bleeding. |
| Bleeding between periods. |
| Absent menstrual periods. |
Coding menorrhagia as unspecified abnormal uterine bleeding (AUB) without sufficient documentation leads to inaccurate severity reflection and potential downcoding.
Failing to document the cause, frequency, and duration of bleeding affects accurate code assignment (e.g., menorrhagia vs. metrorrhagia) and reimbursement.
Overlooking associated conditions like fibroids or coagulopathies during coding and auditing can lead to incomplete clinical picture and missed CC/MCC capture.
Q: What are the most effective diagnostic approaches for differentiating between common causes of abnormal uterine bleeding (AUB), such as leiomyomas, adenomyosis, and endometrial hyperplasia in perimenopausal women?
A: Diagnosing the underlying cause of abnormal uterine bleeding (AUB), especially in perimenopausal women, requires a multi-faceted approach. Transvaginal ultrasound is often the first-line imaging modality, offering good visualization of uterine fibroids (leiomyomas) and assessing endometrial thickness. However, it may not always clearly distinguish between adenomyosis and other conditions. MRI offers superior soft tissue contrast and can be valuable in differentiating adenomyosis from leiomyomas and other pathologies. Endometrial biopsy, guided by hysteroscopy or performed blindly, is crucial for excluding endometrial hyperplasia or malignancy, particularly in women with risk factors like obesity or unopposed estrogen exposure. Consider implementing a diagnostic algorithm that combines these modalities based on individual patient risk factors and initial findings. Explore how a combination of imaging and histopathology can enhance diagnostic accuracy in complex AUB cases. Learn more about the latest ACOG guidelines for managing AUB in perimenopausal women.
Q: How can I effectively manage heavy menstrual bleeding (menorrhagia) in a patient with von Willebrand disease while minimizing treatment risks?
A: Managing menorrhagia in patients with von Willebrand disease (VWD) requires a careful balance between controlling bleeding and minimizing potential complications. First-line therapy often includes combined oral contraceptives or hormonal IUDs to regulate the menstrual cycle and reduce bleeding volume. Tranexamic acid can be used as an adjunctive therapy during menses to further control bleeding. Desmopressin (DDAVP) may be considered for some VWD subtypes, but it carries a risk of hyponatremia and should be used cautiously with appropriate monitoring. For patients unresponsive to these measures, consider referral to a hematologist specializing in bleeding disorders. Explore how individualized treatment plans can address the specific needs and VWD subtype of your patient. Learn more about the current guidelines for managing VWD and menorrhagia.
Patient presents with complaints consistent with abnormal menstrual bleeding (AMB). The patient describes [frequency, duration, and flow of menses; e.g., prolonged menses lasting greater than seven days, heavy menstrual bleeding with soaking through one or more pads or tampons per hour, or irregular menstrual cycles]. She reports [associated symptoms, e.g., intermenstrual bleeding, dysmenorrhea, pelvic pain, fatigue, or shortness of breath]. Menorrhagia is suspected as a primary diagnosis, though other potential causes of irregular menstrual bleeding, including [list differentials; e.g., fibroids, adenomyosis, endometrial polyps, coagulopathy, or hormonal imbalances], are being considered. A detailed menstrual history was obtained, including menarche age, cycle length and regularity, and history of prior abnormal uterine bleeding episodes. Physical examination revealed [relevant findings; e.g., normal pelvic exam, pale conjunctiva, or uterine tenderness]. Initial laboratory studies were ordered, including a complete blood count (CBC) to assess for anemia, coagulation studies to rule out bleeding disorders, and thyroid stimulating hormone (TSH) to evaluate thyroid function. Depending on the lab results and further clinical assessment, additional investigations, such as pelvic ultrasound, endometrial biopsy, or hormonal testing, may be indicated. Patient education was provided regarding potential causes, diagnostic procedures, and management options for heavy menstrual bleeding. Treatment options will be discussed after further diagnostic workup and will be tailored to the underlying cause of the AMB. This may include medical management with hormonal therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), or tranexamic acid, or procedural interventions such as dilation and curettage (D&C) or endometrial ablation. The patient was advised to schedule a follow-up appointment to review the results and discuss the next steps in her care plan. ICD-10 code N92.0 (Excessive and frequent menstruation) is considered for billing purposes, subject to confirmation following completion of diagnostic evaluation.